Jarosław Dybko

667 total citations
44 papers, 344 citations indexed

About

Jarosław Dybko is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Jarosław Dybko has authored 44 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 19 papers in Oncology and 12 papers in Genetics. Recurrent topics in Jarosław Dybko's work include Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Polyomavirus and related diseases (8 papers). Jarosław Dybko is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Polyomavirus and related diseases (8 papers). Jarosław Dybko collaborates with scholars based in Poland, United States and Australia. Jarosław Dybko's co-authors include Donata Urbaniak‐Kujda, Katarzyna Kapelko‐Słowik, Dariusz Wołowiec, Kazimierz Kuliczkowski, Bożena Jaźwiec, Monika Biernat, Tomasz Wróbel, Anna Bohdanowicz-Pawlak, Jacek Daroszewski and Dorota Dłubek and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Jarosław Dybko

40 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jarosław Dybko Poland 12 119 116 93 78 63 44 344
Katarzyna Kapelko‐Słowik Poland 11 78 0.7× 84 0.7× 94 1.0× 83 1.1× 85 1.3× 25 336
László Rejtő Hungary 9 62 0.5× 143 1.2× 108 1.2× 60 0.8× 59 0.9× 33 376
Ci Pan China 14 107 0.9× 96 0.8× 70 0.8× 55 0.7× 34 0.5× 37 405
Mami Inayama Japan 7 107 0.9× 64 0.6× 112 1.2× 32 0.4× 54 0.9× 18 474
Anup J. Devasia India 11 92 0.8× 254 2.2× 115 1.2× 23 0.3× 54 0.9× 79 392
Silvia Manfroi Italy 13 103 0.9× 302 2.6× 167 1.8× 51 0.7× 46 0.7× 34 491
Anna Colpo Italy 11 71 0.6× 104 0.9× 133 1.4× 46 0.6× 59 0.9× 24 376
Uqba Khan United States 12 168 1.4× 40 0.3× 86 0.9× 27 0.3× 86 1.4× 34 394
Grégoire Berthod Switzerland 10 298 2.5× 41 0.4× 119 1.3× 35 0.4× 123 2.0× 24 433
Yonggong Yang China 11 89 0.7× 118 1.0× 90 1.0× 77 1.0× 23 0.4× 33 325

Countries citing papers authored by Jarosław Dybko

Since Specialization
Citations

This map shows the geographic impact of Jarosław Dybko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarosław Dybko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarosław Dybko more than expected).

Fields of papers citing papers by Jarosław Dybko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarosław Dybko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarosław Dybko. The network helps show where Jarosław Dybko may publish in the future.

Co-authorship network of co-authors of Jarosław Dybko

This figure shows the co-authorship network connecting the top 25 collaborators of Jarosław Dybko. A scholar is included among the top collaborators of Jarosław Dybko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarosław Dybko. Jarosław Dybko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dybko, Jarosław, et al.. (2024). Post polycythemia vera myelofibrosis with myelodysplastic-like progression in a patient with chronic lymphocytic leukemia. Polskie Archiwum Medycyny Wewnętrznej. 134(6).
3.
Szlasa, Wojciech, et al.. (2024). Efficient combination of radiotherapy and CAR-T – A systematic review. Biomedicine & Pharmacotherapy. 174. 116532–116532. 15 indexed citations
4.
5.
Dybko, Jarosław, et al.. (2023). The Benefits of the Post-Transplant Cyclophosphamide in Both Haploidentical and Mismatched Unrelated Donor Setting in Allogeneic Stem Cells Transplantation. International Journal of Molecular Sciences. 24(6). 5764–5764. 5 indexed citations
6.
Dybko, Jarosław, et al.. (2023). Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in the Prophylaxis of Graft-Versus-Host Disease: A Systematic Review. Journal of Clinical Medicine. 12(17). 5449–5449. 2 indexed citations
7.
Gil, Lidia, Bartosz Puła, Piotr Boguradzki, et al.. (2020). Allogeneic hematopoietic cell transplantation for multiple myeloma: A retrospective analysis of the Polish Myeloma Group. Advances in Medical Sciences. 65(2). 429–436. 4 indexed citations
8.
Biernat, Monika, et al.. (2020). Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature. Journal of International Medical Research. 48(6). 1220725245–1220725245. 25 indexed citations
9.
Dybko, Jarosław, et al.. (2018). The role of hypoxia-inducible factors in leukemias. Advances in Clinical and Experimental Medicine. 27(2). 271–275. 5 indexed citations
10.
Pawlak, Edyta, Lidia Karabon, Anna Pokryszko‐Dragan, et al.. (2017). PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS. Journal of Neuroimmunology. 305. 115–127. 21 indexed citations
11.
Sobas, Marta, Tomasz Wróbel, Maria Podolak‐Dawidziak, et al.. (2017). Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report. SHILAP Revista de lepidopterología. 2017. 1–4. 5 indexed citations
12.
13.
Urbaniak‐Kujda, Donata, Katarzyna Kapelko‐Słowik, Jarosław Dybko, et al.. (2015). Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma. Hematology. 21(1). 26–33. 21 indexed citations
14.
Urbaniak‐Kujda, Donata, et al.. (2015). The use of hyperbaric oxygen therapy in the treatment of hemorrhagic cystitis after allogeneic stem cell transplantation from an unrelated donor. International Journal of Hematology. 102(3). 364–367. 10 indexed citations
15.
Dybko, Jarosław, Olga Haus, Bożena Jaźwiec, et al.. (2014). CD117 (c-kit) Expression on CD34+ Cells Participates in the Cytogenetic Response to Imatinib in Patients with Chronic Myeloid Leukemia in the First Chronic Phase. Acta Haematologica. 132(2). 166–171. 7 indexed citations
16.
Urbaniak‐Kujda, Donata, Anna Bohdanowicz-Pawlak, Katarzyna Kapelko‐Słowik, et al.. (2012). CD8+CD28− Lymphocytes in Peripheral Blood and Serum Concentrations of Soluble Interleukin 6 Receptor are Increased in Patients with Graves’ Orbitopathy and Correlate with Disease Activity. Endocrine Research. 37(2). 89–95. 33 indexed citations
17.
Basak, Grzegorz, Wanda Knopińska‐Posłuszny, Magdalena Matuszak, et al.. (2010). Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience. Annals of Hematology. 90(5). 557–568. 29 indexed citations
18.
Kapelko‐Słowik, Katarzyna, Donata Urbaniak‐Kujda, Dariusz Wołowiec, et al.. (2010). Human Pim-2 Gene Expression in Acute Myeloid and Acute Lymphoblastic Leukemia Patients and Complete Remission. Advances in Clinical and Experimental Medicine. 19(1). 99–104. 1 indexed citations
19.
Wołowiec, Dariusz, Jarosław Dybko, Tomasz Wróbel, et al.. (2006). Circulating sCD138 and Some Angiogenesis‐Involved Cytokines Help to Anticipate the Disease Progression of Early‐Stage B‐Cell Chronic Lymphocytic Leukemia. Mediators of Inflammation. 2006(1). 42394–42394. 17 indexed citations
20.
Dłubek, Dorota, Jarosław Dybko, Barbara Wysoczańska, et al.. (2002). Enrichment of normal progenitors in counter‐flow centrifugal elutriation (CCE) fractions of fresh chronic myeloid leukemia leukapheresis products. European Journal Of Haematology. 68(5). 281–288. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Kapelko‐Słowik Breakdown of academic impact, for papers by László Rejtő Breakdown of academic impact, for papers by Ci Pan Breakdown of academic impact, for papers by Mami Inayama Breakdown of academic impact, for papers by Anup J. Devasia Breakdown of academic impact, for papers by Silvia Manfroi Breakdown of academic impact, for papers by Anna Colpo Breakdown of academic impact, for papers by Uqba Khan Breakdown of academic impact, for papers by Grégoire Berthod Breakdown of academic impact, for papers by Yonggong Yang
Rankless by CCL
2026